Filing Flows › Hims & Hers Health (HIMS) › Q1 2026 › vs Q1 2025
Hims & Hers Health (HIMS) Q1 2026 vs Q1 2025 (year over year)
Hims & Hers Health's revenue rose $22.1M (+4%) from $586M in Q1 2025 to $608M in Q1 2026.
Hims & Hers Health, Q1 2026: revenue $608M (+4% year over year), operating margin -12.9%, net loss $92.1M, operating cash flow $89.4M. The chart draws each line against Q1 2025, the increases inside each band.
Margins
| Q1 2026 | Q1 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 8.7% | 8.5% | +0.2 pts |
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $608M | $586M | $22.1M | +4% |
| Income tax benefit | $9.4M | −$11.0M | $20.4M | — |
| Net loss | $92.1M | −$49.5M | $142M | — |
| Costs & expenses | $710M | $589M | $121M | +21% |
| Operating costs | $686M | $528M | $158M | +30% |
| Interest & other, net | $23.2M | −$2.6M | $25.8M | — |
| Cost of revenue | $211M | $155M | $56.0M | +36% |
| General & admin | $110M | $48.6M | $61.1M | +126% |
| Other operating costs | $365M | $324M | $41.3M | +13% |
| Operating cash sources | $181M | $59.6M | $122M | +204% |
| Depreciation & amortization | $22.0M | $8.3M | $13.7M | +165% |
| Share-based compensation | $36.9M | $24.9M | $12.0M | +48% |
| Working capital & other | $123M | $26.5M | $96.2M | +363% |
| Net loss absorbed | $92.1M | −$49.5M | $142M | — |
| Operating cash flow | $89.4M | $109M | −$19.7M | -18% |
| Free Cash Flow (company-reported) | $53.0M | $50.1M | $3.0M | +6% |
| Purchases of property, equipment, and intangible assets in investing activities | $29.8M | $55.3M | −$25.5M | -46% |
| Investment in website development and internal-use software in investing activities | $6.5M | $3.7M | $2.8M | +75% |
Questions
How much did Hims & Hers Health's revenue grow year over year in Q1 2026?
Hims & Hers Health's revenue rose $22.1M (+4%) from $586M in Q1 2025 to $608M in Q1 2026.